Athira Pharma, Inc. - Common Stock, $0.0001 par value (ATHA)

Historical Holders from Q3 2020 to Q1 2025

Symbol
ATHA on Nasdaq
CUSIP
04746L104
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
38.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
17.9M
Holdings value
$10.5M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
55
Number of buys
11
Number of sells
-28
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Athira Pharma, Inc. - Common Stock, $0.0001 par value (ATHA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BML Investment Partners, L.P. 7.8% $862K 3.03M Leonard Braden Michael Dec 31, 2024
Oliveira Steven Michael 5.11% $568K 1.99M Steven Michael Oliveira Apr 14, 2025

Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 par value (ATHA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 108K $30.7K $0.28 4
2024 Q4 17.9M $10.5M +$1.18M $0.59 55
2024 Q3 16.1M $7.19M -$16.9M $0.45 57
2024 Q2 22.2M $58.8M +$1.29M $2.65 65
2024 Q1 21.7M $59.4M -$97.7K $2.74 73
2023 Q4 21.9M $53.2M -$1.8M $2.43 64
2023 Q3 21.4M $43.3M -$1.35M $2.02 70
2023 Q2 21.9M $64.6M -$5.34M $2.95 75
2023 Q1 23.8M $59.5M -$1.18M $2.50 81
2022 Q4 21.7M $68.9M +$2.74M $3.17 88
2022 Q3 19.4M $57.7M -$236K $2.97 91
2022 Q2 19.1M $58.3M -$99.3M $3.05 84
2022 Q1 25.8M $348M -$1.42M $13.50 98
2021 Q4 26.2M $341M +$17.6M $13.03 95
2021 Q3 24.9M $234M +$136K $9.38 91
2021 Q2 24.7M $253M -$61.4M $10.24 86
2021 Q1 26.3M $484M +$83.8M $18.40 68
2020 Q4 21.5M $733M +$29M $34.25 69
2020 Q3 21.7M $395M +$395M $18.46 54